1. Evaluation of a new selective agar medium for detection of carbapenem-resistant Enterobacteriaceae
- Author
-
Teruo Kirikae, Jun-ichiro Sekiguchi, Kyoko Kuwahara-Arai, Ayaka Morito, Izumi Yanagisawa, Htay Htay Tin, San Mya, Tatsuya Tada, Mari Tohya, Shin Watanabe, Tomomi Hishinuma, and Khin Nyein Zan
- Subjects
0301 basic medicine ,Microbiology (medical) ,food.ingredient ,030106 microbiology ,Ceftazidime ,Lactose ,Carbapenem-resistant enterobacteriaceae ,Microbial Sensitivity Tests ,Meropenem ,Sensitivity and Specificity ,beta-Lactamases ,Microbiology ,Agar plate ,03 medical and health sciences ,0302 clinical medicine ,Cloxacillin ,food ,Bacterial Proteins ,Enterobacteriaceae ,polycyclic compounds ,medicine ,Agar ,Humans ,030212 general & internal medicine ,biology ,Enterobacteriaceae Infections ,General Medicine ,biochemical phenomena, metabolism, and nutrition ,bacterial infections and mycoses ,biology.organism_classification ,Anti-Bacterial Agents ,Culture Media ,Infectious Diseases ,Carbapenem-Resistant Enterobacteriaceae ,Fermentation ,bacteria ,Vancomycin ,medicine.drug - Abstract
CRE-JU is a novel selective agar for carbapenem-resistant Enterobacteriaceae that contains ceftazidime, cloxacillin, meropenem, and vancomycin. This study evaluated the ability of 63 carbapenem-resistant isolates and 53 non-carbapenem-resistant Enterobacteriaceae strains clinically isolated in Japan, Myanmar, Nepal, and Vietnam to grow on CRE-JU. CRE-JU showed 92.1% sensitivity and 100% specificity for detecting carbapenem-resistant Enterobacteriaceae compared with dug susceptibility profiles.
- Published
- 2019